Welcome to the RAND Drug Policy Research Center

Providing decisionmakers with rigorous, nonpartisan research on substance use and drug policy

Since 1989, the RAND Drug Policy Research Center has conducted research to help decisionmakers in the United States and throughout the world address issues involving alcohol and other drugs. In doing so, the Center brings an objective and data-driven perspective to this often emotional and fractious policy arena.

Recent Commentaries

Browse All Drug Policy and Trends Commentary

RAND DPRC Research Making an Impact

L.A. Holds Hearing on Proposed Cannabis Advertising Restrictions

Citing research by Liz D'Amico and a host of other RAND researchers, the City of Los Angeles is proposing an ordinance that recommends restricting cannabis advertising near schools and other "sensitive locations," including alcoholism or drug abuse recovery or treatment facilities, public libraries, public parks, schools, and residentially zoned property. A public hearing was held on December 14, 2017.

Funding for the Fight Against the Opioid Epidemic

Rosalie Pacula testified before the House Appropriations Committee about the evidence and effectiveness of different drug policy strategies for addressing the opioid epidemic.

Cannabis Legislation in Canada

Beau Kilmer provided testimony to the Canadian legislature on different alternatives to prohibition, including considerations for prices, taxes, and international implications.

Medical Marijuana Policy in Florida

Rosalie Pacula testified before the Florida House of Representatives Health & Human Services Committee on medical marijuana regulation, including topics of supply structure, commercialization, and potential impact on youth.